Nu Skin Enterprises, Inc.
Nu Skin Enterprises, Inc. (NUS) Stock Competitors & Peer Comparison
See (NUS) competitors and their performances in Stock Market.
Peer Comparison Table: Household & Personal Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NUS | $8.75 | -2.34% | 432.4M | -10.94 | -$0.80 | +2.73% |
| PG | $158.30 | -0.32% | 371.2B | 25.13 | $6.30 | +2.61% |
| UL | $60.43 | -1.00% | 148.3B | 22.55 | $2.68 | +3.22% |
| CL | $87.93 | -0.59% | 71.3B | 24.92 | $3.53 | +2.32% |
| KVUE | $22.84 | +1.51% | 43.9B | 40.82 | $0.56 | +3.61% |
| KMB | $127.38 | -0.29% | 42.3B | 17.35 | $7.34 | +3.90% |
| EL | $90.40 | +4.18% | 32.5B | -37.36 | -$2.42 | +1.91% |
| CHD | $97.23 | -0.05% | 23.9B | 41.72 | $2.33 | +1.19% |
| CLX | $130.81 | -0.46% | 16.1B | 23.49 | $5.57 | +3.73% |
| SGI | $74.72 | +1.14% | 15.6B | 47.87 | $1.56 | +0.40% |
Stock Comparison
NUS vs PG Comparison July 2025
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 432.4M. In comparison, PG has a market cap of 371.2B. Regarding current trading prices, NUS is priced at $8.75, while PG trades at $158.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of -10.94, whereas PG's P/E ratio is 25.13. In terms of profitability, NUS's ROE is -0.06%, compared to PG's ROE of +0.30%. Regarding short-term risk, NUS is more volatile compared to PG. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check PG's competition here
NUS vs UL Comparison July 2025
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 432.4M. In comparison, UL has a market cap of 148.3B. Regarding current trading prices, NUS is priced at $8.75, while UL trades at $60.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of -10.94, whereas UL's P/E ratio is 22.55. In terms of profitability, NUS's ROE is -0.06%, compared to UL's ROE of +0.29%. Regarding short-term risk, NUS is more volatile compared to UL. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check UL's competition here
NUS vs CL Comparison July 2025
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 432.4M. In comparison, CL has a market cap of 71.3B. Regarding current trading prices, NUS is priced at $8.75, while CL trades at $87.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of -10.94, whereas CL's P/E ratio is 24.92. In terms of profitability, NUS's ROE is -0.06%, compared to CL's ROE of +10.23%. Regarding short-term risk, NUS is more volatile compared to CL. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check CL's competition here
NUS vs KVUE Comparison July 2025
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 432.4M. In comparison, KVUE has a market cap of 43.9B. Regarding current trading prices, NUS is priced at $8.75, while KVUE trades at $22.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of -10.94, whereas KVUE's P/E ratio is 40.82. In terms of profitability, NUS's ROE is -0.06%, compared to KVUE's ROE of +0.10%. Regarding short-term risk, NUS is more volatile compared to KVUE. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check KVUE's competition here
NUS vs KMB Comparison July 2025
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 432.4M. In comparison, KMB has a market cap of 42.3B. Regarding current trading prices, NUS is priced at $8.75, while KMB trades at $127.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of -10.94, whereas KMB's P/E ratio is 17.35. In terms of profitability, NUS's ROE is -0.06%, compared to KMB's ROE of +2.26%. Regarding short-term risk, NUS is more volatile compared to KMB. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check KMB's competition here
NUS vs EL Comparison July 2025
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 432.4M. In comparison, EL has a market cap of 32.5B. Regarding current trading prices, NUS is priced at $8.75, while EL trades at $90.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of -10.94, whereas EL's P/E ratio is -37.36. In terms of profitability, NUS's ROE is -0.06%, compared to EL's ROE of -0.18%. Regarding short-term risk, NUS is more volatile compared to EL. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check EL's competition here
NUS vs CHD Comparison July 2025
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 432.4M. In comparison, CHD has a market cap of 23.9B. Regarding current trading prices, NUS is priced at $8.75, while CHD trades at $97.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of -10.94, whereas CHD's P/E ratio is 41.72. In terms of profitability, NUS's ROE is -0.06%, compared to CHD's ROE of +0.18%. Regarding short-term risk, NUS is more volatile compared to CHD. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check CHD's competition here
NUS vs CLX Comparison July 2025
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 432.4M. In comparison, CLX has a market cap of 16.1B. Regarding current trading prices, NUS is priced at $8.75, while CLX trades at $130.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of -10.94, whereas CLX's P/E ratio is 23.49. In terms of profitability, NUS's ROE is -0.06%, compared to CLX's ROE of +7.42%. Regarding short-term risk, NUS is more volatile compared to CLX. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check CLX's competition here
NUS vs SGI Comparison July 2025
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 432.4M. In comparison, SGI has a market cap of 15.6B. Regarding current trading prices, NUS is priced at $8.75, while SGI trades at $74.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of -10.94, whereas SGI's P/E ratio is 47.87. In terms of profitability, NUS's ROE is -0.06%, compared to SGI's ROE of +0.26%. Regarding short-term risk, NUS is more volatile compared to SGI. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check SGI's competition here
NUS vs HIMS Comparison July 2025
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 432.4M. In comparison, HIMS has a market cap of 12.4B. Regarding current trading prices, NUS is priced at $8.75, while HIMS trades at $57.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of -10.94, whereas HIMS's P/E ratio is 84.76. In terms of profitability, NUS's ROE is -0.06%, compared to HIMS's ROE of +0.36%. Regarding short-term risk, NUS is less volatile compared to HIMS. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check HIMS's competition here
NUS vs ELF Comparison July 2025
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 432.4M. In comparison, ELF has a market cap of 6.9B. Regarding current trading prices, NUS is priced at $8.75, while ELF trades at $120.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of -10.94, whereas ELF's P/E ratio is 62.93. In terms of profitability, NUS's ROE is -0.06%, compared to ELF's ROE of +0.24%. Regarding short-term risk, NUS is more volatile compared to ELF. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check ELF's competition here
NUS vs NTCO Comparison July 2025
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 432.4M. In comparison, NTCO has a market cap of 4.6B. Regarding current trading prices, NUS is priced at $8.75, while NTCO trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of -10.94, whereas NTCO's P/E ratio is -11.37. In terms of profitability, NUS's ROE is -0.06%, compared to NTCO's ROE of -0.49%. Regarding short-term risk, NUS is more volatile compared to NTCO. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check NTCO's competition here
NUS vs COTY Comparison July 2025
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 432.4M. In comparison, COTY has a market cap of 4.5B. Regarding current trading prices, NUS is priced at $8.75, while COTY trades at $5.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of -10.94, whereas COTY's P/E ratio is -10.88. In terms of profitability, NUS's ROE is -0.06%, compared to COTY's ROE of -0.10%. Regarding short-term risk, NUS is more volatile compared to COTY. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check COTY's competition here
NUS vs IPAR Comparison July 2025
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 432.4M. In comparison, IPAR has a market cap of 3.9B. Regarding current trading prices, NUS is priced at $8.75, while IPAR trades at $121.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of -10.94, whereas IPAR's P/E ratio is 23.41. In terms of profitability, NUS's ROE is -0.06%, compared to IPAR's ROE of +0.31%. Regarding short-term risk, NUS is more volatile compared to IPAR. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check IPAR's competition here
NUS vs NWL Comparison July 2025
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 432.4M. In comparison, NWL has a market cap of 2.6B. Regarding current trading prices, NUS is priced at $8.75, while NWL trades at $6.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of -10.94, whereas NWL's P/E ratio is -10.63. In terms of profitability, NUS's ROE is -0.06%, compared to NWL's ROE of -0.09%. Regarding short-term risk, NUS is less volatile compared to NWL. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check NWL's competition here
NUS vs SPB Comparison July 2025
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 432.4M. In comparison, SPB has a market cap of 1.5B. Regarding current trading prices, NUS is priced at $8.75, while SPB trades at $60.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of -10.94, whereas SPB's P/E ratio is 28.42. In terms of profitability, NUS's ROE is -0.06%, compared to SPB's ROE of +0.03%. Regarding short-term risk, NUS is more volatile compared to SPB. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check SPB's competition here
NUS vs EPC Comparison July 2025
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 432.4M. In comparison, EPC has a market cap of 1.3B. Regarding current trading prices, NUS is priced at $8.75, while EPC trades at $27.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of -10.94, whereas EPC's P/E ratio is 15.79. In terms of profitability, NUS's ROE is -0.06%, compared to EPC's ROE of +0.05%. Regarding short-term risk, NUS is more volatile compared to EPC. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check EPC's competition here
NUS vs HELE Comparison July 2025
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 432.4M. In comparison, HELE has a market cap of 553.5M. Regarding current trading prices, NUS is priced at $8.75, while HELE trades at $24.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of -10.94, whereas HELE's P/E ratio is -1.66. In terms of profitability, NUS's ROE is -0.06%, compared to HELE's ROE of -0.22%. Regarding short-term risk, NUS is less volatile compared to HELE. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check HELE's competition here
NUS vs SLSN Comparison July 2025
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 432.4M. In comparison, SLSN has a market cap of 304.2M. Regarding current trading prices, NUS is priced at $8.75, while SLSN trades at $4.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of -10.94, whereas SLSN's P/E ratio is 86.80. In terms of profitability, NUS's ROE is -0.06%, compared to SLSN's ROE of +0.24%. Regarding short-term risk, NUS is less volatile compared to SLSN. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check SLSN's competition here
NUS vs SKIN Comparison July 2025
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 432.4M. In comparison, SKIN has a market cap of 225.6M. Regarding current trading prices, NUS is priced at $8.75, while SKIN trades at $1.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of -10.94, whereas SKIN's P/E ratio is -5.26. In terms of profitability, NUS's ROE is -0.06%, compared to SKIN's ROE of -0.68%. Regarding short-term risk, NUS is less volatile compared to SKIN. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check SKIN's competition here
NUS vs EWCZ Comparison July 2025
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 432.4M. In comparison, EWCZ has a market cap of 222.8M. Regarding current trading prices, NUS is priced at $8.75, while EWCZ trades at $5.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of -10.94, whereas EWCZ's P/E ratio is 25.70. In terms of profitability, NUS's ROE is -0.06%, compared to EWCZ's ROE of +0.13%. Regarding short-term risk, NUS is more volatile compared to EWCZ. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check EWCZ's competition here
NUS vs ACU Comparison July 2025
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 432.4M. In comparison, ACU has a market cap of 162.6M. Regarding current trading prices, NUS is priced at $8.75, while ACU trades at $43.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of -10.94, whereas ACU's P/E ratio is 16.82. In terms of profitability, NUS's ROE is -0.06%, compared to ACU's ROE of +0.05%. Regarding short-term risk, NUS is more volatile compared to ACU. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check ACU's competition here
NUS vs DSY Comparison July 2025
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 432.4M. In comparison, DSY has a market cap of 74.8M. Regarding current trading prices, NUS is priced at $8.75, while DSY trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of -10.94, whereas DSY's P/E ratio is 43.67. In terms of profitability, NUS's ROE is -0.06%, compared to DSY's ROE of -0.03%. Regarding short-term risk, NUS is more volatile compared to DSY. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check DSY's competition here
NUS vs GROV Comparison July 2025
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 432.4M. In comparison, GROV has a market cap of 61.1M. Regarding current trading prices, NUS is priced at $8.75, while GROV trades at $1.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of -10.94, whereas GROV's P/E ratio is -1.96. In terms of profitability, NUS's ROE is -0.06%, compared to GROV's ROE of -1.66%. Regarding short-term risk, NUS is more volatile compared to GROV. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check GROV's competition here
NUS vs RAY Comparison July 2025
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 432.4M. In comparison, RAY has a market cap of 46.1M. Regarding current trading prices, NUS is priced at $8.75, while RAY trades at $2.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of -10.94, whereas RAY's P/E ratio is 43.67. In terms of profitability, NUS's ROE is -0.06%, compared to RAY's ROE of +0.16%. Regarding short-term risk, NUS is less volatile compared to RAY. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check RAY's competition here
NUS vs UG Comparison July 2025
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 432.4M. In comparison, UG has a market cap of 39M. Regarding current trading prices, NUS is priced at $8.75, while UG trades at $8.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of -10.94, whereas UG's P/E ratio is 13.46. In terms of profitability, NUS's ROE is -0.06%, compared to UG's ROE of +0.33%. Regarding short-term risk, NUS is less volatile compared to UG. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check UG's competition here
NUS vs PHH Comparison July 2025
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 432.4M. In comparison, PHH has a market cap of 21.8M. Regarding current trading prices, NUS is priced at $8.75, while PHH trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of -10.94, whereas PHH's P/E ratio is 41.40. In terms of profitability, NUS's ROE is -0.06%, compared to PHH's ROE of +0.38%. Regarding short-term risk, NUS is less volatile compared to PHH. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check PHH's competition here
NUS vs MTEX Comparison July 2025
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 432.4M. In comparison, MTEX has a market cap of 15.4M. Regarding current trading prices, NUS is priced at $8.75, while MTEX trades at $8.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of -10.94, whereas MTEX's P/E ratio is -73.55. In terms of profitability, NUS's ROE is -0.06%, compared to MTEX's ROE of -0.03%. Regarding short-term risk, NUS is less volatile compared to MTEX. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check MTEX's competition here
NUS vs BRSH Comparison July 2025
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 432.4M. In comparison, BRSH has a market cap of 8.7M. Regarding current trading prices, NUS is priced at $8.75, while BRSH trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of -10.94, whereas BRSH's P/E ratio is -0.01. In terms of profitability, NUS's ROE is -0.06%, compared to BRSH's ROE of +1.19%. Regarding short-term risk, NUS is less volatile compared to BRSH. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check BRSH's competition here
NUS vs TANH Comparison July 2025
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 432.4M. In comparison, TANH has a market cap of 2.8M. Regarding current trading prices, NUS is priced at $8.75, while TANH trades at $2.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of -10.94, whereas TANH's P/E ratio is -0.01. In terms of profitability, NUS's ROE is -0.06%, compared to TANH's ROE of -0.03%. Regarding short-term risk, NUS is more volatile compared to TANH. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check TANH's competition here
NUS vs TKLF Comparison July 2025
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 432.4M. In comparison, TKLF has a market cap of 1.7M. Regarding current trading prices, NUS is priced at $8.75, while TKLF trades at $3.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of -10.94, whereas TKLF's P/E ratio is 2.46. In terms of profitability, NUS's ROE is -0.06%, compared to TKLF's ROE of +0.11%. Regarding short-term risk, NUS is more volatile compared to TKLF. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check TKLF's competition here
NUS vs BRSHW Comparison July 2025
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 432.4M. In comparison, BRSHW has a market cap of 6.1K. Regarding current trading prices, NUS is priced at $8.75, while BRSHW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of -10.94, whereas BRSHW's P/E ratio is N/A. In terms of profitability, NUS's ROE is -0.06%, compared to BRSHW's ROE of +1.19%. Regarding short-term risk, NUS is less volatile compared to BRSHW. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check BRSHW's competition here
NUS vs SUMR Comparison July 2025
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 432.4M. In comparison, SUMR has a market cap of 0. Regarding current trading prices, NUS is priced at $8.75, while SUMR trades at $11.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of -10.94, whereas SUMR's P/E ratio is -3.66. In terms of profitability, NUS's ROE is -0.06%, compared to SUMR's ROE of -0.75%. Regarding short-term risk, NUS is more volatile compared to SUMR. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check SUMR's competition here
NUS vs REV Comparison July 2025
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 432.4M. In comparison, REV has a market cap of 0. Regarding current trading prices, NUS is priced at $8.75, while REV trades at $3.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of -10.94, whereas REV's P/E ratio is -1.19. In terms of profitability, NUS's ROE is -0.06%, compared to REV's ROE of +0.89%. Regarding short-term risk, NUS is less volatile compared to REV. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check REV's competition here